PCI The Journeys Within
CPHI 2026 – 23/07/2026

Current Edition

ramusmedical
Europe

How aspirin and omega-3 may reduce cancer risk

Acetylsalicylic acid, best known as aspirin, and omega-3 fatty acids support various aspects of health, and scientists continue to uncover how these substances work. ...
Continue Reading →
Europe

Danish malaria vaccine passes test in humans

For many years, a team of researchers at the University of Copenhagen have been focussing on developing a vaccine that can protect against the disease pregnancy malar...
Continue Reading →
Europe

Clinigen Extends Exclusive European Clinical Trial Sourcing and Supply Agreement with Accord Healthcare

First of its kind, ‘on demand’ supply service for clinical trials to be offered Burton-on-Trent, England, January 10, 2019 / -- Clinigen Group plc (AIM: CLIN, ‘Clinig...
Continue Reading →
Europe

New England Journal of Medicine publishes positive results of the pivotal trial of Cablivi® (caplacizumab) for rare blood clotting disorder

HERCULES Phase 3 trial met its primary endpoint, demonstrating that treatment with Cablivi resulted in a significantly faster time to platelet count response in p...
Continue Reading →
Europe

CarThera obtains ANSM approval to launch its Phase I-II clinical trial for the SonoCloud-9 device in the treatment of recurrent glioblastoma

Paris, France, January 15, 2019 - CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today ann...
Continue Reading →
Europe

Align Clinical CRO Publishes New Operational Data Exchange Standard for Life Sciences Industry Input

Industry group’s first technology standard to make it easier for sponsors and CROs to share information during clinical trials. BARCELONA, Spain — 15 January 2019 — ...
Continue Reading →
news

Pfizer initiates phase 2b/3 clinical trial for PF-06651600, an oral JAK3 inhibitor, for the treatment of patients with moderate to severe alopecia areata

Pfizer Inc. (NYSE: PFE) announced the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for the treatment of patients with moderate ...
Continue Reading →
news

Phase 3 Trial of Rova T as Second-line Therapy for Advanced Small-Cell Lung Cancer Halted

AbbVie , a research-based global biopharmaceutical company, announced the decision to stop enrollment for the TAHOE trial, a Phase 3 study evaluating Rovalpituzumab ...
Continue Reading →
Europe

Nanobiotix and MD Anderson Cancer Center announce a large-scale, comprehensive clinical collaboration on NBTXR3

Collaboration will initially support nine new phase I/II clinical trials with Nanobiotix’s first-in-class agent NBTXR3 for use in treating six cancer types - head ...
Continue Reading →
Europe

Clinical Trial Launches to Develop Breath Test for Multiple Cancers

Cancer Research UK recruits first patients in trial to improve the early detection and diagnosis of different cancer types Study will use Owlstone Medical’s Brea...
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026